{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:21:31Z","timestamp":1787775691829,"version":"build-2784847793"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004160","name":"Mazandaran University of Medical Sciences","doi-asserted-by":"publisher","award":["2672"],"award-info":[{"award-number":["2672"]}],"id":[{"id":"10.13039\/501100004160","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.jgar.2018.09.004","type":"journal-article","created":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T20:51:30Z","timestamp":1537476690000},"page":"11-16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Potent in vitro antileishmanial activity of a nanoformulation of cisplatin with carbon nanotubes against Leishmania major"],"prefix":"10.1016","volume":"16","author":[{"given":"Javad","family":"Akhtari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roghiyeh","family":"Faridnia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamed","family":"Kalani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Bastani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdi","family":"Fakhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Rezvan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4724-0373","authenticated-orcid":false,"given":"Amin Kazemi","family":"Beydokhti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2018.09.004_bib0005","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.amsu.2017.07.057","article-title":"Medicinal plants with promising antileishmanial activity in Iran: a systematic review and meta-analysis","volume":"21","author":"Soosaraei","year":"2017","journal-title":"Ann Med Surg (Lond)"},{"key":"10.1016\/j.jgar.2018.09.004_bib0010","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.apjtm.2016.09.014","article-title":"Promising antileishmanial effectiveness of doxorubicin and Doxil against Leishmania major: an in vitro assay","volume":"10","author":"Shokri","year":"2017","journal-title":"Asian Pac J Trop Dis"},{"key":"10.1016\/j.jgar.2018.09.004_bib0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005739","article-title":"A new perspective on cutaneous leishmaniasis\u2014implications for global prevalence and burden of disease estimates","volume":"11","author":"Bailey","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.jgar.2018.09.004_bib0020","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1007\/s12639-015-0730-9","article-title":"In vitro anti-leishmanial activity of Satureja hortensis and Artemisia dracunculus extracts on Leishmania major promastigotes","volume":"40","author":"Mirzaei","year":"2016","journal-title":"J Parasit Dis"},{"key":"10.1016\/j.jgar.2018.09.004_bib0025","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.tmaid.2006.09.004","article-title":"Cutaneous Leishmaniasis treatment","volume":"5","author":"Minodier","year":"2007","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.jgar.2018.09.004_bib0030","doi-asserted-by":"crossref","DOI":"10.5812\/jjnpp.63754","article-title":"In vitro antileishmanial activity of Falcaria vulgaris fractions on Leishmania major","volume":"12","author":"Eskandarian","year":"2017","journal-title":"Jundishapur J Nat Pharm Prod"},{"issue":"Suppl. 3","key":"10.1016\/j.jgar.2018.09.004_bib0035","doi-asserted-by":"crossref","first-page":"S257","DOI":"10.1016\/j.medmal.2007.08.001","article-title":"Cardiotoxicity of n-methyl-glucamine antimoniate (Glucantime). A case report","volume":"37","author":"Matoussi","year":"2007","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.jgar.2018.09.004_bib0040","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1590\/S0036-46651999000100007","article-title":"Nephrotoxicity attributed to meglumine antimoniate (Glucantime) in the treatment of generalized cutaneous Leishmaniasis","volume":"41","author":"Rodrigues","year":"1999","journal-title":"Rev Inst Med Trop S\u00e3o Paulo"},{"key":"10.1016\/j.jgar.2018.09.004_bib0045","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.4155\/fmc.13.143","article-title":"Drug resistance in leishmaniasis: current drug-delivery systems and future perspectives","volume":"5","author":"Yasinzai","year":"2013","journal-title":"Future Med Chem"},{"key":"10.1016\/j.jgar.2018.09.004_bib0050","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1745-6673-2-16","article-title":"Nanotechnology-based drug delivery systems","volume":"2","author":"Suri","year":"2007","journal-title":"J Occup Med Toxicol"},{"key":"10.1016\/j.jgar.2018.09.004_bib0055","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S1773-2247(14)50121-9","article-title":"Microwave functionalized single-walled carbon nanotube as nanocarrier for the delivery of anticancer drug cisplatin: in vitro and in vivo evaluation","volume":"24","author":"Kazemi-Beydokhti","year":"2014","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.jgar.2018.09.004_bib0060","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1049\/mnl.2014.0593","article-title":"Experimental investigation of thermal conductivity of medical nanofluids based on functionalised single-wall carbon nanotube and conjugated cisplatin","volume":"10","author":"Kazemi-Beydokhti","year":"2015","journal-title":"Micro Nano Lett"},{"key":"10.1016\/j.jgar.2018.09.004_bib0065","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.cherd.2016.06.006","article-title":"Investigation of different methods for cisplatin loading using single-walled carbon nanotube","volume":"112","author":"Kazemi-Beydokhti","year":"2016","journal-title":"Chem Eng Res Des"},{"key":"10.1016\/j.jgar.2018.09.004_bib0070","doi-asserted-by":"crossref","first-page":"5289","DOI":"10.2147\/IJN.S140363","article-title":"Nanostructured delivery systems with improved leishmanicidal activity: a critical review","volume":"12","author":"Bruni","year":"2017","journal-title":"\u200eInt J Nanomed"},{"key":"10.1016\/j.jgar.2018.09.004_bib0075","doi-asserted-by":"crossref","first-page":"e525","DOI":"10.1016\/j.ijid.2011.03.021","article-title":"Recent advances in leishmaniasis treatment","volume":"15","author":"Tiuman","year":"2011","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jgar.2018.09.004_bib0080","first-page":"29","article-title":"Investigating in vitro anti-leishmanial effects of silibinin and silymarin on Leishmania major","volume":"64","author":"Faridnia","year":"2018","journal-title":"Ann Parasitol"},{"key":"10.1016\/j.jgar.2018.09.004_bib0085","doi-asserted-by":"crossref","first-page":"433","DOI":"10.2174\/092986708783503221","article-title":"Anticancer compounds as leishmanicidal drugs: challenges in chemotherapy and future perspectives","volume":"15","author":"Perez","year":"2008","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.jgar.2018.09.004_bib0090","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.actatropica.2007.05.017","article-title":"Characterization of the anti-Leishmania effect induced by cisplatin, an anticancer drug","volume":"103","author":"Tavares","year":"2007","journal-title":"Acta Trop"},{"key":"10.1016\/j.jgar.2018.09.004_bib0095","first-page":"433","article-title":"The isolation and characterization of murine macrophages","volume":"15","author":"Zhang","year":"2008","journal-title":"Curr Protoc Immunol"},{"key":"10.1016\/j.jgar.2018.09.004_bib0100","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.actatropica.2016.12.027","article-title":"In vitro antileishmanial activity of novel azoles (3-imidazolylflavanones) against promastigote and amastigote stages of Leishmania major","volume":"167","author":"Shokri","year":"2017","journal-title":"Acta Trop"},{"key":"10.1016\/j.jgar.2018.09.004_bib0105","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12906-018-2128-6","article-title":"In vitro antileishmanial and cytotoxicity activities of essential oils from Haplophyllum tuberculatum A. Juss leaves, stems and aerial parts","volume":"18","author":"Hamdi","year":"2018","journal-title":"BMC Complement Altern Med"},{"key":"10.1016\/j.jgar.2018.09.004_bib0110","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/j.addr.2013.08.005","article-title":"Carbon nanotubes for delivery of small molecule drugs","volume":"65","author":"Wong","year":"2013","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.jgar.2018.09.004_bib0115","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1517\/17425247.2013.751370","article-title":"Targeted drug delivery to macrophages","volume":"10","author":"Jain","year":"2013","journal-title":"\u200eExpert Opin Drug Deliv"},{"key":"10.1016\/j.jgar.2018.09.004_bib0120","first-page":"689","article-title":"Novel applications of nanotechnology in medicine","volume":"130","author":"Surendiran","year":"2009","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.jgar.2018.09.004_bib0125","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1016\/j.bmc.2009.02.043","article-title":"Nanoparticles in cellular drug delivery","volume":"17","author":"Faraji","year":"2009","journal-title":"Bioorganic Med Chem"},{"key":"10.1016\/j.jgar.2018.09.004_bib0130","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.parint.2014.07.008","article-title":"Carbon nanotube based betulin formulation shows better efficacy against Leishmania parasite","volume":"63","author":"Saudagar","year":"2014","journal-title":"Parasitol Int"},{"key":"10.1016\/j.jgar.2018.09.004_bib0135","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1093\/jac\/dkr002","article-title":"Targeted killing of Leishmania donovani in vivo and in vitro with amphotericin B attached to functionalized carbon nanotubes","volume":"66","author":"Prajapati","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2018.09.004_bib0140","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/infdis\/jir735","article-title":"An oral formulation of amphotericin B attached to functionalized carbon nanotubes is an effective treatment for experimental visceral Leishmaniasis","volume":"205","author":"Prajapati","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jgar.2018.09.004_bib0145","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.pt.2003.09.008","article-title":"Leishmaniasis\u2014current chemotherapy and recent advances in the search for novel drugs","volume":"19","author":"Croft","year":"2003","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.jgar.2018.09.004_bib0150","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2147\/IJN.S596","article-title":"Drug delivery and nanoparticles: applications and hazards","volume":"3","author":"De Jong","year":"2008","journal-title":"\u200eInt J Nanomed"},{"key":"10.1016\/j.jgar.2018.09.004_bib0155","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1039\/C5CS00674K","article-title":"New approaches from nanomedicine for treating leishmaniasis","volume":"45","author":"Guti\u00e9rrez","year":"2016","journal-title":"Chem Soc Rev"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716518301772?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716518301772?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:52:51Z","timestamp":1761990771000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716518301772"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":31,"alternative-id":["S2213716518301772"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2018.09.004","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potent in vitro antileishmanial activity of a nanoformulation of cisplatin with carbon nanotubes against Leishmania major","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2018.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 International Society for Chemotherapy of Infection and Cancer. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}